Promises of Nanotherapeutics in Obesity

33Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The application of nanotechnology to medicine promises a wide range of new tools and possibilities, from earlier diagnostics and improved imaging, to better, more efficient, and more targeted therapies. This emerging field could help address obesity, with advances in drug delivery, nutraceuticals, and genetic and epigenetic therapeutics. Its application to obesity is still largely in the development phase. Here, we review the novel angle of nanotech applied to human consumable products and their specific applications to addressing obesity through nutraceuticals, with respect to benefits and limitations of current nanotechnology methods. Further, we review potential future applications to deliver genetic and epigenetic miRNA therapeutics. Finally, we discuss future directions, including theranostics, combinatory therapy, and personalized medicine.

Cite

CITATION STYLE

APA

Ash, G. I., Kim, D., & Choudhury, M. (2019, June 1). Promises of Nanotherapeutics in Obesity. Trends in Endocrinology and Metabolism. Elsevier Inc. https://doi.org/10.1016/j.tem.2019.04.004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free